InsidersTradesSigma
인바디 Stock: price and insider trades · South Korea · DART (FSS)
Track the 인바디 stock price and the full insider trade history of the company, a listed equity based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, 인바디 has recorded 32 reports. Market capitalisation: €778.1bn. The latest transaction was disclosed on 3 July 2026 (Other). Among the most active insiders: 차인준. The full history is free.
32
Insider Decl.
0
Thresholds
·
6 ops.
Buy Volume
·
2 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 인바디 Buy (bullish), based on 1 analysts. Average price target: ₩74,000.
23Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 4,662 of 26,134 companies
68.2
score / 100
Value52
Quality85
FCF yld3.9%
Earn yld4.3%
EV/EBITDA15.3x
ROE·
Gross mgn77%
Net mgn13%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2026
Declarations32 total
149,804 sharesKRXDART:20260428000253
25 of 32 declarations
About 인바디
InBody is a company specializing in the development of body composition measurement technologies. It is listed on the XKRX market.